Roche Holding AG's Headquarters As Drugmaker Acquires InterMune Inc. For $8.3 Billion

Electric lighting illuminates office windows inside an office building at Roche Holdings AG's plant in Rotkreuz, Switzerland, on Tuesday, Aug. 26, 2014. Roche, the world's largest maker of cancer drugs, is strengthening its portfolio of medicines for respiratory ailments with an agreement to buy InterMune Inc. for $8.3 billion in cash. Photographer: Philipp Schmidli/Bloomberg via Getty Images
Electric lighting illuminates office windows inside an office building at Roche Holdings AG's plant in Rotkreuz, Switzerland, on Tuesday, Aug. 26, 2014. Roche, the world's largest maker of cancer drugs, is strengthening its portfolio of medicines for respiratory ailments with an agreement to buy InterMune Inc. for $8.3 billion in cash. Photographer: Philipp Schmidli/Bloomberg via Getty Images
Roche Holding AG's Headquarters As Drugmaker Acquires InterMune Inc. For $8.3 Billion
PURCHASE A LICENCE
How can I use this image?
£375.00
GBP

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
454241920
Collection:
Bloomberg
Date created:
26 August, 2014
Upload date:
Licence type:
Release info:
Not released. More information
Source:
Bloomberg
Object name:
SWISS ROCHE INTERMUNE